Variant report
Variant | nsv974203 |
---|---|
Chromosome Location | chr13:53835362-53839610 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559211154 | chr13:53835420-53835421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs549153363 | chr13:53835474-53835475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565985404 | chr13:53835488-53835489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534717600 | chr13:53835492-53835493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs554507261 | chr13:53835558-53835559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs574476443 | chr13:53835601-53835602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs55915021 | chr13:53835602-53835603 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs557165864 | chr13:53835639-53835640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs576196318 | chr13:53835649-53835650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs7318473 | chr13:53835665-53835666 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs565201767 | chr13:53835711-53835712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs188529163 | chr13:53835713-53835714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs9563146 | chr13:53835721-53835722 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs560893342 | chr13:53835759-53835760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs181558914 | chr13:53835792-53835793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549887339 | chr13:53835794-53835795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs148178513 | chr13:53835796-53835797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs56963510 | chr13:53835800-53835801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs185736143 | chr13:53835857-53835858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs7317854 | chr13:53835889-53835890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs532742389 | chr13:53835900-53835901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs190726967 | chr13:53835953-53835954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs540810432 | chr13:53835966-53835967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566047462 | chr13:53835972-53835973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs9563147 | chr13:53835990-53835991 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs554840099 | chr13:53835995-53835996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs145150097 | chr13:53836080-53836081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537011411 | chr13:53836180-53836181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs115780022 | chr13:53836274-53836275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs182229999 | chr13:53836305-53836306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs1322950 | chr13:53836325-53836326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187328788 | chr13:53836334-53836335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs190951465 | chr13:53836362-53836363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572250113 | chr13:53836460-53836461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs76278937 | chr13:53836486-53836487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs561154701 | chr13:53836513-53836514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs574381519 | chr13:53836532-53836533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543002434 | chr13:53836553-53836554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs544395112 | chr13:53836604-53836605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs369776348 | chr13:53836605-53836606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563418619 | chr13:53836612-53836613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs562858130 | chr13:53836618-53836619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs150950963 | chr13:53836630-53836631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs9568834 | chr13:53836655-53836656 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs74086930 | chr13:53836656-53836657 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs528652970 | chr13:53836665-53836666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs76007339 | chr13:53836667-53836668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs115805546 | chr13:53836685-53836686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs139504583 | chr13:53836689-53836690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs182294816 | chr13:53836735-53836736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 19242612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Multiple myeloma | 19135901 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21858162 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Gastric cancer | 17908304 | CNVD |
Breast cancer | 18852474 | CNVD |
Myelofibrosis | 22110671 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Schizophrenia | 20967226 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:53834200-53835400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr13:53834600-53836000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr13:53835200-53836000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr13:53836000-53843800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |